Among more than 140,000 visits for ear infection, only 15% used watchful waiting, but treatment failure rates were low and ...
Half of the Staphylococcus epidermidis isolates found in raw milk from dairy cattle and sheep were multidrug resistant.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Raw cow and sheep milk is frequently contaminated with antibiotic-resistant bacteria that could pose a threat to human and ...
Do you want to be less anxious or more cheerful? Emerging research points to the role of gut microbes in defining your ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Abstract: In this paper, we detect bacteria from Gram stained smears images by the object detectors of SSD, M2Det, RT-DETR and YOLOv8. Then, we show that SSD and M2Det are not appropriate for ...
Life is Wisdom on MSN
From Persistent Pain to Clarity: Unraveling Small Intestinal Bacterial Overgrowth (SIBO) and Its Impact on Your Health
Picture this: you’re at your local chai stall in Mumbai, finally sinking your teeth into that vada pav you’ve been ...
Animal tests show promise to target invasive strain of E. coli but approval for use in humans is still years away ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Live Science on MSN
Antibiotic found hiding in plain sight could treat dangerous infections, early study finds
Scientists have discovered a never-before-seen antibiotic that shows promising in treating drug-resistant infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback